CIRSE Registry for SIR-Spheres Therapy
NCT: NCT02305459 · COMPLETED
Brief Summary
The administration of SIR-Spheres microspheres (yttrium-90 resin microspheres) is a form of selective internal radiation therapy (SIRT) for the treatment of patients with primary and secondary liver tumours. The primary objective is to observe the real-life clinical application of radioembolisation with SIR-Spheres and the impact of the treatment in clinical practice. Secondary objectives are to observe safety and effectiveness of SIR-Spheres treatment in terms of adverse events, Overall Survival (OS), Progression-free survival (PFS), technical considerations, liver PFS and Quality of Life (QoL) + subgroup analyses
Frequently Asked Questions
What is CIRSE Registry for SIR-Spheres Therapy?
CIRSE Registry for SIR-Spheres Therapy is a clinical trial registered under NCT02305459. Current status: COMPLETED.
What is the status of NCT02305459?
The current status of NCT02305459 (CIRSE Registry for SIR-Spheres Therapy) is: COMPLETED.
When did CIRSE Registry for SIR-Spheres Therapy start?
CIRSE Registry for SIR-Spheres Therapy started on 2014-11.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.